Month: November 2016

Staples, Inc. SPLS is scheduled to report third-quarter fiscal 2016 results on Nov 17. […]

Newmont Mining Corporation NEM said that its Long Canyon mine located 100 miles from its existing Nevada complex poured first gold on Nov 8 and the company anticipates declaring commercial production next week. The operation was completed two months before schedule for just below $225 million which was about $50 million or 18% below budget. […]

Baltimore-based Legg Mason Inc. LM reported a fall in its assets under management (AUM) as of Oct 31, 2016, as compared with the prior month. Preliminary month-end AUM came in at $716.3 billion, down 2.3% from Sep 2016. […]

Post-Britain’s exit from the European Union, Citigroup Inc. C is formulating the relocation of up to 900 jobs from London to Dublin. This is part of the company’s contingency plan to deal with the growing uncertainties of Brexit […]

Sanofi SNY presented full results from a pharmacokinetic/pharmacodynamic (PK/PD) study on Toujeo in comparison with insulin degludec for the treatment of type 1 diabetes at the 16th Annual Diabetes Technology Meeting, Bethesda, MD. The randomized double-blind study on Toujeo (insulin glargine 300 Units/mL) demonstrated an overall flat PK/PD profile and a more evenly distributed exposure over 24 hours in the Toujeo arm, compared to insulin degludec, at both the dose levels (0.4 and 0.6 U/kg/day). Moreover, Toujeo was found to have a more favorable safety profile than Degludec […]

AbbVie Inc. ABBV announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has given a positive recommendation for the label expansion of its lead prescription drug, Humira for the treatment of active moderate-to-severe hidradenitis suppurativa (HS) in adolescents aged 12 years and above. In Jul last year, Humira was granted marketing approval for the same indication in adults by the European Commission. […]

Eli Lilly and Company LLY announced that new data presented at the American Heart Association Scientific Sessions 2016 from long-term cardiovascular (CV) outcomes study of its diabetes medicine Jardiance showed that the drug was effective in reducing the risk for cardiovascular death. The results, which are part of the landmark EMPA-REG OUTCOME trial, showed that irrespective of the type of cardiovascular disease at baseline, Jardiance tablets reduced the risk of cardiovascular death in adults with type II diabetes and established cardiovascular disease compared to placebo when added to standard of care. Cardiovascular disease is very common in adults with type II diabetes. […]

Large-cap pharma stock, Bristol-Myers Squibb Company BMY has come up with updates on its pipeline. The company announced preliminary data from a phase I/II open-label study, CheckMate-032, on Opdivo, in combination with Yervoy, for the treatment of locally advanced or metastatic urothelial carcinoma (mUC) in patients who have been previously treated with platinum-based therapy. Data demonstrated a confirmed objective response rate of 38.5% in patients who received Opdivo (1 mg/kg) plus Yervoy (3 mg/kg) […]

AstraZeneca PLC AZN announced phase III study results for its well-known product for asthma, Symbicort. The study showed that the drug improves lung function in pediatric asthma patients aged six to twelve years. […]

Kilroy Realty Corporation KRC recently announced that it has roped in the reputed software company – Adobe – as its anchor tenant for the 100 Hooper development. Specifically, the company broke ground on 100 Hooper – a $270 million, 400,000 square foot project in the SOMA district of San Francisco – and struck a long-term lease deal with Adobe. Per this deal, the software firm would occupy 207,000 square feet or around 65% of 100 Hooper’s office space […]

Last week was all about earnings in the telecom sector. Several sector participants declared their third-quarter 2016 financial numbers, the overall results being a mixed bag. United States Cellular Corp […]

The Buckle, Inc. BKE is slated to release third-quarter fiscal 2016 results on Nov 18. […]